SonaCare Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SonaCare Medical's estimated annual revenue is currently $34.4M per year.(i)
  • SonaCare Medical's estimated revenue per employee is $251,000

Employee Data

  • SonaCare Medical has 137 Employees.(i)
  • SonaCare Medical grew their employee count by 21% last year.

SonaCare Medical's People

NameTitleEmail/Phone
1
CEO & PresidentReveal Email/Phone
2
Director Process ImprovementReveal Email/Phone
3
Product Support TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.3M37-5%N/AN/A
#2
$16.6M6610%N/AN/A
#3
$5.5M22-8%N/AN/A
#4
$32.1M12829%N/AN/A
#5
$20.3M815%N/AN/A
#6
$34.4M13721%N/AN/A
#7
$7M2887%N/AN/A
#8
$18.6M74-4%N/AN/A
#9
$45.4M1810%N/AN/A
#10
$8.3M33N/AN/AN/A
Add Company

What Is SonaCare Medical?

USHIFU, based in Charlotte, NC, is a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies. Dr. Schoenberg holds no equity in USHIFU.

keywords:N/A

N/A

Total Funding

137

Number of Employees

$34.4M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SonaCare Medical News

2022-04-20 - High Intensity Focused Ultrasound (HIFU) Market Size 2022 ...

... (HIFU) Market Size 2022-2030| Key Players – Chongqing Haifu Medical Technology, Alpinion Medical Systems, Philips Healthcare, SonaCare Medical.

2022-04-20 - High Intensity Focused Ultrasound Devices Market Size ...

... EDAP TMS, Haifu Medical, Koninklijke Philips N.V, Medtronic Plc, SonaCare Medical, LLC, Stryker Corporation, SuperSonic, Ultrasound Technologies Ltd.

2022-04-19 - Therapeutic Ultrasound Devices Market Size, Outlook And ...

... Devices Market Size, Outlook And Forecast | EDAP TMS, Dornier Medtech, InSightec, Siemens, Philips Healthcare, SonaCare Medical, Wikkon.

2014-10-06 - Prostate cancer: FDA panel recommends against approval for SonaCare’s Sonablate

SonaCare Medical said it will reposition its Sonablate prostate cancer device to treat a more aggressive stage of the disease after an FDA panel last week failed to recommend approval for the device. The FDA’s Gastroenterology & Urology Devices panel voted 7-3 with 1 abstention that the SonaCar ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37M1376%N/A
#2
$17.9M1381%$42.2M
#3
$19.3M138-4%$3M
#4
$30.4M138-1%N/A
#5
$20.9M139-5%N/A